☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
bioheng therapeutics
Bioheng Therapeutics Secures the FDA Clearance of IND Application for CTD402 in T-ALL/LBL
March 5, 2025
Load more...
Back to Home
Modal title
×
Modal body text goes here.